Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 7 Prostatic Neoplasms 3 Myasthenia Gravis 3 Plasmacytoma 2 Paraproteinemias 2 Neoplasms 2 Neoplasm Metastasis 2 Leukemia, Plasma Cell 2 Hemangioma 2 Breast Neoplasms 2 Spinal Cord Compression 1 Recurrence 1 Radiation Injuries 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma 1 Hepatitis 1 Head and Neck Neoplasms 1 Glioma 1 Gallstones 1 Esophageal Stenosis 1 Esophageal Neoplasms 1 Disease Progression 1 Common Bile Duct Neoplasms 1 Common Bile Duct Diseases 1 Colorectal Neoplasms 1

Interventions

Rituximab 305 Cyclophosphamide 287 Etoposide 125 fludarabine phosphate 124 Peripheral Blood Stem Cell Transplantation 107 fludarabine 104 Filgrastim 103 Melphalan 91 Mycophenolic Acid 87 Whole-Body Irradiation 80 Vincristine 80 Cytarabine 77 Busulfan 77 Doxorubicin 71 Radiotherapy 70 Prednisone 67 Cyclosporine 67 Tacrolimus 64 Bendamustine Hydrochloride 61 Methotrexate 56 Granulocyte Colony-Stimulating Factor 56 Antilymphocyte Serum 50 Carmustine 48 Dexamethasone 44 Gemcitabine 42 Lenalidomide 41 venetoclax 39 Bortezomib 35 obinutuzumab 33 ibritumomab tiuxetan 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡